Cardiovascular Revascularization Medicine
Volume 8, Issue 3 , Pages 170-174 , July 2007

Four-year results after brachytherapy for diffuse coronary in-stent restenosis: will coronary radiation therapy survive?

Received 28 July 2006 ,Revised 27 September 2006 ,Accepted 27 September 2006.

References 

  1. Waksman R, Bhargava B, White L, Chan RC, Mehran R, Lansky AJ, et al. Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation. 2000;101:1895–1898
  2. Silber S, Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, et al. Two-year clinical follow-up of 90Sr/90Y beta-radiation versus placebo control for the treatment of in-stent restenosis. Am Heart J. 2005;149(4):689–694
  3. Rha SW, Kuchulakanti P, Ajani AE, Cheneau E, Pinnow EE, Canos DA, et al. Three-year follow-up after intravascular gamma-radiation for in-stent restenosis in saphenous vein grafts. Catheter Cardiovasc Interv. 2005;65(2):257–262
  4. Holmes DR, Teirstein P, Satler L, Sketch M, O'Malley J, Popma JJ, et al. Sirolimus-eluting stents vs. vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA. 2006;295(11):1264–1273
  5. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, et al. Paclitaxel-eluting stents vs. vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA. 2006;295(11):1253–1263
  6. Haase J, von Neumann-Cosel P, Damm M, Hofmann M, Störger H, Isner D, et al. Comparison of a centered 32P source wire system with a noncentered 90Sr/Y brachytherapy system for intracoronary beta-radiation following PCI of diffuse in-stent restenosis. Cardiovasc Revasc Med. 2005;6(4):140–146
  7. King SB, Williams DO, Chougule P, Klein JL, Waksman R, Hilstead R, et al. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: results of the Beta Energy Restenosis Trial (BERT). Circulation. 1998;97:2025–2030
  8. Raizner AE, Calfee RV, Ali MN, Bradshaw AJ, Eno RP. The Guidant coronary source wire system. In:  Waksman R editors. Vascular brachytherapy. New York: Futura Publishing Co.; 1999;p. 505–519
  9. Arjomand H, Turi ZG, McCormick D, Goldberg S. Percutaneous coronary intervention: historical perspectives, current status and future directions. Am Heart J. 2003;146:787–796
  10. Nguyen-Ho P, Kaluza GL, Zymek PT, Raizner AE. Intracoronary brachytherapy. Catheter Cardiovasc Interv. 2002;56:281–1288
  11. Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, et al. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation. 2002;106(9):1090–1096
  12. Waksman R, Raizner AE, Yeung AC, Lansky AJ, Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet. 2002;359(9306):551–557
  13. Grise MA, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, et al. Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation. 2002;105(23):2737–2740
  14. Waksman R, Ajani AE, White RL, Chan R, Bass B, Pichard AD, et al. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation. 2004;109(3):340–344
  15. Haase J, Jung T, Störger H, Hofmann M, Reinemer H, Schwarz C, et al. Long-term outcome after implantation of bare metal stents fort he treatment of coronary artery disease. J Interv Cardiol. 2003;16:469–473
  16. Teirstein PS, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, et al. Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation. 2000;101:360–365
  17. Chu WW, Torguson R, Pichard AD, Satler LF, Chan R, Porrazzo M, et al. Drug-eluting stets versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation. J Invasive Cardiol. 2005;17:659–662
  18. Kaluza GL, Raizner AE. Brachytherapy for restenosis after stenting for coronary artery disease: its role in the drug-eluting stent era. Curr Opin Cardiol. 2004;19:601–607
  19. Torguson R, Deible R, Smith K, Chu WW, Kent KM, Pichard AD, et al. Intravascular brachytherapy versus repeat drug-eluting stenting for the treatment of patients with drug-eluting stent restenosis. J Am Coll Cardiol. 2006;47(Suppl 2):B43;[Abstract]
  20. Colombo A, Corbett SJ. Drug-eluting stent thrombosis. J Am Coll Cardiol. 2006;48:203–205
  21. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193–202

PII: S1553-8389(06)00234-X

doi: 10.1016/j.carrev.2006.09.005

Cardiovascular Revascularization Medicine
Volume 8, Issue 3 , Pages 170-174 , July 2007

Article Tools

* Image Usage & Resolution